Jiangsu Apon Medical Technology Co., Ltd. (SHE:300753)
China · Delayed Price · Currency is CNY 21.86
+0.71 (3.36%)
Aug 25, 2026, 10:25 AM CST
SHE:300753 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 2,666 | 3,498 | 2,222 | 2,164 | 2,278 | 2,558 | |
Market Cap Growth | -37.90% | 57.40% | 2.68% | -4.98% | -10.94% | -3.76% |
Enterprise Value | 2,679 | 3,462 | 2,151 | 2,068 | 2,192 | 2,396 |
Last Close Price | 21.15 | 27.75 | 17.58 | 17.03 | 17.92 | 20.12 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | 205.75 | 261.47 | - | 47.31 |
Forward PE | - | 29.75 | 29.75 | 29.75 | 29.75 | 29.75 |
PS Ratio | 7.72 | 10.23 | 5.50 | 5.13 | 7.03 | 5.55 |
PB Ratio | 3.95 | 5.15 | 3.14 | 3.10 | 3.32 | 3.28 |
P/TBV Ratio | 4.92 | 6.41 | 3.65 | 3.55 | 3.82 | 3.78 |
P/FCF Ratio | 353.22 | - | 407.60 | - | - | - |
P/OCF Ratio | 168.35 | 1499.33 | 141.73 | - | - | 139.86 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 7.75 | 10.12 | 5.33 | 4.90 | 6.77 | 5.19 |
EV/EBITDA Ratio | - | - | 65.15 | 84.99 | - | 39.34 |
EV/EBIT Ratio | - | - | 119.53 | 177.29 | - | 49.79 |
EV/FCF Ratio | 355.00 | - | 394.61 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.15 | 0.18 | 0.12 | 0.11 | 0.10 | 0.05 |
Debt / EBITDA Ratio | 24.47 | - | 2.10 | 2.51 | - | 0.63 |
Debt / FCF Ratio | 13.06 | - | 15.03 | - | - | - |
Net Debt / Equity Ratio | 0.00 | -0.06 | -0.17 | -0.18 | -0.26 | -0.30 |
Net Debt / EBITDA Ratio | -1.30 | 2.80 | -3.65 | -5.20 | 2.70 | -3.86 |
Net Debt / FCF Ratio | 0.28 | 7.18 | -22.13 | 2.34 | 3.71 | 11.02 |
Asset Turnover | 0.42 | 0.40 | 0.47 | 0.49 | 0.37 | 0.53 |
Inventory Turnover | 1.72 | 1.84 | 2.16 | 2.50 | 2.55 | 3.36 |
Quick Ratio | 2.12 | 2.05 | 2.94 | 2.84 | 2.52 | 5.30 |
Current Ratio | 2.91 | 2.59 | 3.65 | 3.41 | 3.03 | 6.33 |
Return on Equity (ROE) | -1.98% | -3.87% | 1.55% | 1.22% | -10.38% | 7.01% |
Return on Assets (ROA) | -1.14% | -2.14% | 1.31% | 0.84% | -5.70% | 3.48% |
Return on Invested Capital (ROIC) | -2.31% | -4.83% | 1.60% | 1.33% | -15.35% | 10.34% |
Return on Capital Employed (ROCE) | -2.20% | -4.20% | 2.40% | 1.60% | -11.20% | 5.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | -0.40% | -0.69% | 0.49% | 0.38% | -3.34% | 2.11% |
FCF Yield | 0.28% | -0.17% | 0.24% | -2.50% | -2.14% | -0.83% |
Dividend Yield | - | - | 0.37% | 0.38% | - | - |
Payout Ratio | - | - | 89.34% | 16.04% | - | 58.29% |
Buyback Yield / Dilution | 0.06% | 0.00% | -0.03% | 0.05% | 0.00% | -0.00% |
Total Shareholder Return | 0.06% | 0.00% | 0.34% | 0.43% | 0.00% | -0.00% |